The goal of this work was to explore the chemistry and the physics of a family of molecule-based magnets containing three spin carriers, with a fully interlocked structure. The main emphasis was on the coercivity of these magnets, which confers a memory effect on the materials. stands for the radical cation 2-(1-ethylpyridinium-4-yl)-4,4,5,5-tetramethylimidazolin-1-oxyl-3-oxide, and opba stands for ortho-phenylenebis-(oxamato). The crystal structures of the three compounds have been determined. The structure of 1 consists of planar Cu(opba) units with one of the radical cations weakly bound to the Cu 2 ion, the other radical cation being rather isolated. Compounds 2 and 3 are isomorphous. Their structure consists of two interpenetrating graphitelike networks with edge-sharing hexagons. The magnetic properties of the three compounds have been investigated in detail. For compounds 2 and 3 the temperature dependences of the direct current (dc) and alternating current (ac) magnetic responses have been measured along with the field dependence of the magnetization. Both compounds exhibit a long-range magnetic ordering with a spontaneous magnetization. The critical temperatures are 22.8 K and 37 K for 2 and 3, respectively. While 2 is a soft magnet, 3 has been found to be a very hard magnet, with a coercive field depending on the particle size. This coercive field may reach 24 kOe at 6 K for a sample consisting of very small crystals. Mixed materials with the abbreviated formula [Etrad 2 Mn 2À2x Co 2x Cu 3 ] (4Àx) have also been synthesized. Their critical temperatures have been found to vary almost linearly with x. The x dependence of the coercive field has also been investigated and analyzed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.